ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Koninklijke Philips NV

Koninklijke Philips NV (PHIA)

24.37
-0.12
(-0.49%)
Cerrado 05 Enero 10:30AM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
24.37
Postura de Compra
24.10
Postura de Venta
24.50
Volume Operado de la Acción
725,697
24.20 Rango del Día 24.50
18.092 Rango de 52 semanas 30.22
Capitalización de Mercado [m]
Precio Anterior
24.49
Precio de Apertura
24.26
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
1,766,134
Acciones en circulación
906,403,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-47.40
Beneficio por acción (BPA)
-0.51
turnover
18.17B
Beneficio neto
-466M

Acerca de Koninklijke Philips NV

Sector
Electrical Machy, Equip, Nec
Industria
Electrical Equipment
Sitio web
Sede
Eindhoven, North Brabant, Nld
Fundado
1984
Koninklijke Philips NV is listed in the Electrical Machy, Equip sector of the Euronext with ticker PHIA. The last closing price for Koninklijke Philips NV was 24.49 €. Over the last year, Koninklijke Philips NV shares have traded in a share price range of 18.092 € to 30.22 €.

Koninklijke Philips NV currently has 906,403,000 shares in issue. The market capitalisation of Koninklijke Philips NV is 22.20 € billion. Koninklijke Philips NV has a price to earnings ratio (PE ratio) of -47.40.

PHIA Últimas noticias

Philips aims to advance cardiac MRI technology through AI-driven research

Philips aims to advance cardiac MRI technology through AI-driven research December 3, 2024 Collaboration intends to leverage proprietary AI technology from Philips and Mayo Clinic to target...

Philips optimizes CT workflows with in-house AI, launches CT 5300 in North America at #RSNA2024

Philips optimizes CT workflows with in-house AI, launches CT 5300 in North America at #RSNA2024 December 1, 2024 Philips CT 5300 combines innovative hardware, software, and artificial...

Better care for more people: Philips innovates in AI-enabled imaging and cloud-based informatics at #RSNA24

Better care for more people: Philips innovates in AI-enabled imaging and cloud-based informatics at #RSNA24 December 1, 2024 Philips' intelligent diagnostic and treatment solutions, combined with...

Philips and AWS expand strategic collaboration to advance HealthSuite cloud services and power generative AI workflows

Philips and AWS expand strategic collaboration to advance HealthSuite cloud services and power generative AI workflows November 26, 2024 Cloud-enabled integrated diagnostics portfolio aims to...

Philips and icometrix advance precision diagnosis in neurology with innovative AI-based imaging solutions at #RSNA24

Philips and icometrix advance precision diagnosis in neurology with innovative AI-based imaging solutions at #RSNA24 November 25, 2024icometrix’ FDA-cleared quantitative brain solution for...

Philips unveils next-generation BlueSeal helium-free MRI system, integrated with AI-enabled Smart Reading at #RSNA24

Philips unveils next-generation BlueSeal helium-free MRI system, integrated with AI-enabled Smart Reading at #RSNA24 Nov. 21, 2024 Industry’s first wide bore, high-performance helium-free [1]...

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease With a unique world-first ability to perform laser atherectomy and...

Philips delivers strong margin improvement; flat comparable sales due to further deteriorated demand in China; growth in rest of world

Philips delivers strong margin improvement; flat comparable sales due to further deteriorated demand in China; growth in rest of world October 28, 2024 Third-quarter highlights Group sales...

Philips and Medtronic advocacy partnership aims to help accelerate access to life-saving treatments

Philips and Medtronic advocacy partnership aims to help accelerate access to life-saving treatments October 24, 2024 Both companies also join the newly established World Stroke Organization...

Siloam Hospitals Group and Philips sign AI capability MoU to support Indonesia’s healthcare transformation strategy

Siloam Hospitals Group and Philips sign AI capability MoU to support Indonesia’s healthcare transformation strategy October 7, 2024 Jakarta, Indonesia and Amsterdam, the Netherlands – Royal...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.16-0.65226253567124.5324.7924.282316124.46413084DE
4-0.42-1.6942315449824.7925.1423.53127461724.42444043DE
12-4.81-16.483893077529.1830.2223.53176613425.49241287DE
260.773.2627118644123.630.2223.34169579826.09796581DE
523.0714.413145539921.330.2218.092191407423.6861077DE
156-8.415-25.667225865532.78533.9312.13282409320.58887712DE
260-19.355-44.26529445443.72550.9812.13278859027.42707124DE

PHIA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Koninklijke Philips NV?
El precio actual de las acciones de Koninklijke Philips NV es 24.37 €
¿Cuántas acciones de Koninklijke Philips NV están en circulación?
Koninklijke Philips NV tiene 906,403,000 acciones en circulación
¿Cuál es la capitalización de mercado de Koninklijke Philips NV?
La capitalización de mercado de Koninklijke Philips NV es EUR 22.2B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Koninklijke Philips NV?
Koninklijke Philips NV ha negociado en un rango de 18.092 € a 30.22 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Koninklijke Philips NV?
El ratio precio/beneficio de Koninklijke Philips NV es -47.4
¿Cuál es el ratio de efectivo a ventas de Koninklijke Philips NV?
El ratio de efectivo a ventas de Koninklijke Philips NV es 1.22
¿Cuál es la moneda de reporte de Koninklijke Philips NV?
Koninklijke Philips NV presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Koninklijke Philips NV?
El último ingresos anual de Koninklijke Philips NV es EUR 18.17B
¿Cuál es el último beneficio anual de Koninklijke Philips NV?
El último beneficio anual de Koninklijke Philips NV es EUR -466M
¿Cuál es la dirección registrada de Koninklijke Philips NV?
La dirección registrada de Koninklijke Philips NV es HIGH TECH CAMPUS 51, 1 FLOOR, EINDHOVEN, NORTH BRABANT, 5656 AG
¿Cuál es la dirección del sitio web de Koninklijke Philips NV?
La dirección del sitio web de Koninklijke Philips NV es www.philips.com
¿En qué sector industrial opera Koninklijke Philips NV?
Koninklijke Philips NV opera en el sector ELECTRICAL EQUIPMENT

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MLFXOFinaxo
0.895 €
(43.20%)
500
MLWEYWeya
0.0175 €
(34.62%)
5.1k
POXELPoxel
0.191 €
(33.57%)
4.22M
ALBIOBiosynex
2.50 €
(28.73%)
50.71k
SEQUASequana medical NV
3.02 €
(23.27%)
1.05M
BNBSTonner Drones
0.0005 €
(-50.00%)
524.03k
ALAGOEPango SA
0.127 €
(-41.20%)
11.94M
EIFDSTour Eiffel DS
0.0032 €
(-38.46%)
33.94k
FINMFinanciere Marjos
0.076 €
(-36.13%)
1.4k
ALALOAcheterLouerFR
0.20 €
(-33.33%)
90.63k
ATOAtos SE
0.0024 €
(-4.00%)
1.53B
BCPBanco Comercial Portugues SA
0.4623 €
(0.74%)
43.69M
ALTDTonner Drones
0.0118 €
(-7.81%)
27.49M
NEOENNeoen SA
39.74 €
(-0.15%)
21.76M
ALVERVergnet
0.002 €
(0.00%)
16.8M
3331 3331 5 minutos hace
BIEL: 911 NEWS COMING!
https://recoveryrx1.carrd.co/
novicetrader novicetrader 5 minutos hace
yes, at any point in time I'm usually in at least 30-35 stocks.Some small positions of course.
BDEZ BDEZ 5 minutos hace
With Johnson back i don't see many changes....
bb8675309 bb8675309 5 minutos hace
xodcode - Their has always been an exaggerated effort here to derail Anavex from being successful by the fudsters. They would not be here if their wasn't anything to the company or their drug line. This is also reinforcing to real investors. They are panicking..
AVXL
QueenVic QueenVic 5 minutos hace
I sent a PM for ya
FMCC
Konaploinks Konaploinks 6 minutos hace
Doc. A Probably Object Framework? Probably. 😜
IONQ
BDEZ BDEZ 6 minutos hace
Horror of Christian/Newsom killings

https://x.com/UltraDane/status/1875989782117142533


https://www.knoxnews.com/story/news/crime/2017/08/24/archives-horror-christian-newsom-killings-focus-what-happened-chipman-street/597805001/
skitahoe skitahoe 6 minutos hace
Dstocks, as I see it, if CRL were planning to be the major supplier of DCVax-L, but they knew that at best FDA approval wouldn't come prior to late 3rd quarter, and more likely 4th quarter or next year, wouldn't you lay off people now, then hire when staffing needed to increase to meet demands for D
NWBO
Gmenfan Gmenfan 7 minutos hace
‘Smoking Gun Bombshell’ Study Confirms Covid ‘Vaccines’ Are Spiked with Cancer Virus

Frank BergmanJanuary 4, 2025 - 12:54 pm

An explosive new peer-reviewed study has just sent shockwaves through the scientific community by confirming that Covid mRNA “vaccines” are laced
Gmenfan Gmenfan 7 minutos hace
‘Smoking Gun Bombshell’ Study Confirms Covid ‘Vaccines’ Are Spiked with Cancer Virus

Frank BergmanJanuary 4, 2025 - 12:54 pm

An explosive new peer-reviewed study has just sent shockwaves through the scientific community by confirming that Covid mRNA “vaccines” are laced
mrfence mrfence 7 minutos hace
When Trump said he'd release the GSE'S and sell the Warrants He had yet to experience the MSM & Deep State lawfare attacks like the GSE'S did and it's in his own best interests to release them anyway. So if Trump plans to reward loyalty, why wouldn't he completely write down the Sen Pref and Warr
jman4956 jman4956 7 minutos hace
Maybe Kelly saw a better opportunity in the DCVax revolution.
NWBO
getmoreshares getmoreshares 8 minutos hace
you should invest in level 2-- or-- at least learn how to read a chart. 5's are next
KATX
DiscoverGold DiscoverGold 8 minutos hace
The AMD weekly chart has demonstrated higher lows for two consecutive weeks on the 5BX, confirming a bottom within our smart money zone...
By: Peter DiCarlo | January 5, 2025

• The AMD weekly chart has demonstrated higher lows for two consecutive weeks on the 5BX, confirmi
AMD
TightCoil TightCoil 9 minutos hace
FANNIE & FREDDIE
Begin tomorrow with
FEAR and TREMBLING
FNMA
StayHumble StayHumble 10 minutos hace
💹546M+ BUYS💹wow Lots of Xperts Here💹 https://ih.advfn.com/stock-market/USOTC/humbl-pk-HMBL/trades
HMBL
Pittkid Pittkid 10 minutos hace
Bash a stock with no money in play! Lol...why are you here! Unless you're getting paid!
HMBL
Konaploinks Konaploinks 10 minutos hace
So instead of an arbitrary object framework, a probably object framework. Probably. 🤪
Gmenfan Gmenfan 10 minutos hace
The comments are always good here:

Klobuchar: No Need to Rush Trump’s Nominees — ‘We Have a Very Functional FBI’

https://www.breitbart.com/clips/2025/01/05/klobuchar-no-need-to-rush-trumps-nominees-we-have-a-very-functional-fbi/
redspinelpinktopaz redspinelpinktopaz 10 minutos hace
All true. That's why we're pulling our hair out.
LWLG
Gmenfan Gmenfan 11 minutos hace
Klobuchar: No Need to Rush Trump’s Nominees — ‘We Have a Very Functional FBI’

I always check out the comments.

https://www.breitbart.com/clips/2025/01/05/klobuchar-no-need-to-rush-trumps-nominees-we-have-a-very-functional-fbi/
Gmenfan Gmenfan 11 minutos hace
Klobuchar: No Need to Rush Trump’s Nominees — ‘We Have a Very Functional FBI’

I always check out the comments.

https://www.breitbart.com/clips/2025/01/05/klobuchar-no-need-to-rush-trumps-nominees-we-have-a-very-functional-fbi/
kund kund 12 minutos hace
We all know what happens when he starts talking....
AVXL
copytele copytele 12 minutos hace
I GAVE YUO # 14 FOLLOW , TRY TO HIT ME BACK.
BTQQF

Su Consulta Reciente

Delayed Upgrade Clock